![]() |
Name |
glucopiericidinol A
|
Molecular Formula | C31H47NO10 | |
IUPAC Name* |
2-[11-hydroxy-13-(4-hydroxy-5,6-dimethoxy-3-methylpyridin-2-yl)-3,5,7,11-tetramethyltrideca-2,6,8,12-tetraen-4-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol
|
|
SMILES |
CC=C(C)C(OC1OC(CO)C(O)C(O)C1O)C(C)C=C(C)C=CCC(C)(O)C=Cc1nc(OC)c(OC)c(O)c1C
|
|
InChI |
InChI=1S/C31H47NO10/c1-9-18(3)27(42-30-26(37)25(36)24(35)22(16-33)41-30)19(4)15-17(2)11-10-13-31(6,38)14-12-21-20(5)23(34)28(39-7)29(32-21)40-8/h9-12,14-15,19,22,24-27,30,33,35-38H,13,16H2,1-8H3,(H,32,34)/b11-10+,14-12+,17-15+,18-9+/t19-,22?,24?,25?,26?,27+,30?,31?/m1/s1
|
|
InChIKey |
FXKCPQKAYSQRGI-DGBRBLTMSA-N
|
|
Synonyms |
NA
|
|
CAS | NA | |
PubChem CID | NA | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 593.71 | ALogp: | 2.6 |
HBD: | 6 | HBA: | 11 |
Rotatable Bonds: | 13 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 171.2 | Aromatic Rings: | 2 |
Heavy Atoms: | 42 | QED Weighted: | 0.146 |
Caco-2 Permeability: | -5.07 | MDCK Permeability: | 0.00000869 |
Pgp-inhibitor: | 0.788 | Pgp-substrate: | 0.985 |
Human Intestinal Absorption (HIA): | 0.799 | 20% Bioavailability (F20%): | 0.009 |
30% Bioavailability (F30%): | 0.948 |
Blood-Brain-Barrier Penetration (BBB): | 0.36 | Plasma Protein Binding (PPB): | 76.97% |
Volume Distribution (VD): | 1.261 | Fu: | 8.32% |
CYP1A2-inhibitor: | 0.005 | CYP1A2-substrate: | 0.246 |
CYP2C19-inhibitor: | 0.014 | CYP2C19-substrate: | 0.795 |
CYP2C9-inhibitor: | 0.002 | CYP2C9-substrate: | 0.124 |
CYP2D6-inhibitor: | 0.004 | CYP2D6-substrate: | 0.142 |
CYP3A4-inhibitor: | 0.57 | CYP3A4-substrate: | 0.581 |
Clearance (CL): | 2.543 | Half-life (T1/2): | 0.541 |
hERG Blockers: | 0.057 | Human Hepatotoxicity (H-HT): | 0.912 |
Drug-inuced Liver Injury (DILI): | 0.033 | AMES Toxicity: | 0.047 |
Rat Oral Acute Toxicity: | 0.087 | Maximum Recommended Daily Dose: | 0.558 |
Skin Sensitization: | 0.622 | Carcinogencity: | 0.049 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.007 |
Respiratory Toxicity: | 0.121 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC002660 | ![]() |
0.609 | D06BQU | ![]() |
0.246 | ||
ENC004854 | ![]() |
0.605 | D0B8UJ | ![]() |
0.232 | ||
ENC003820 | ![]() |
0.518 | D0T5BC | ![]() |
0.225 | ||
ENC003819 | ![]() |
0.462 | D0H3KI | ![]() |
0.222 | ||
ENC001847 | ![]() |
0.352 | D02VCJ | ![]() |
0.219 | ||
ENC001625 | ![]() |
0.338 | D0B1IP | ![]() |
0.213 | ||
ENC005616 | ![]() |
0.305 | D01TNW | ![]() |
0.210 | ||
ENC005126 | ![]() |
0.302 | D0D0SH | ![]() |
0.209 | ||
ENC002201 | ![]() |
0.300 | D05ZYM | ![]() |
0.208 | ||
ENC002883 | ![]() |
0.296 | D0TC7C | ![]() |
0.207 |